Hodgkin's disease in the United States: a comparison of patient characteristics and survival in the Centralized Cancer Patient Data System and the Surveillance, Epidemiology, and End Results Program
- PMID: 3469461
Hodgkin's disease in the United States: a comparison of patient characteristics and survival in the Centralized Cancer Patient Data System and the Surveillance, Epidemiology, and End Results Program
Abstract
Demographic, pathologic, and clinical characteristics as well as subsequent survival were compared between 3,607 Hodgkin's disease (HD) patients registered by the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute and 2,278 HD patients registered by comprehensive cancer centers (CCCs) belonging to the Centralized Cancer Patient Data System (CCPDS). All patients were diagnosed with HD between July 1977 and December 1982. CCPDS cases were slightly younger, more often of the nodular sclerosing histologic type, and presented with Stage II disease at diagnosis more often than did SEER cases. CCPDS and SEER cases were similar regarding the lymph node region of origin, sex, and race. The mortality rate among SEER patients was approximately 1.5 times that among CCPDS patients. This significant survival difference was observed within all stages and within all histologic subtypes and remained after controlling for the effects of age. Late-stage, older age, non-Caucasian race, and a more diffuse histologic appearance were all independent and significant predictors of poor survival. These findings suggest that the management of HD in CCCs results in improved outcome relative to that in the general population. Possible explanations for such effects are explored, and additional lines of pursuit are suggested.
Similar articles
-
Characteristics of colon cancer patients reported in population-based tumor registries and Comprehensive Cancer Centers.J Natl Cancer Inst. 1983 Apr;70(4):629-34. J Natl Cancer Inst. 1983. PMID: 6572750
-
Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.J Urol. 2003 Nov;170(5):1765-71. doi: 10.1097/01.ju.0000091620.86778.2e. J Urol. 2003. PMID: 14532772
-
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.Oncologist. 1996;1(5):326-330. Oncologist. 1996. PMID: 10388011
-
Hodgkin's and non-Hodgkin's lymphoma of the head and neck.Laryngoscope. 2001 Sep;111(9):1565-9. doi: 10.1097/00005537-200109000-00013. Laryngoscope. 2001. PMID: 11568605
-
[Comprehensive epidemiologic and clinico-pathologic study of Hodgkin's disease].Orv Hetil. 1989 Apr 23;130(17):869-74. Orv Hetil. 1989. PMID: 2662127 Review. Hungarian.
Cited by
-
The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphoma.Dtsch Arztebl Int. 2012 Dec;109(51-52):893-9. doi: 10.3238/arztebl.2012.0893. Epub 2012 Dec 24. Dtsch Arztebl Int. 2012. PMID: 23372613 Free PMC article. Clinical Trial.
-
Centralised treatment, entry to trials and survival.Br J Cancer. 1994 Aug;70(2):352-62. doi: 10.1038/bjc.1994.306. Br J Cancer. 1994. PMID: 8054285 Free PMC article.
-
Establishing cancer units.Br J Cancer. 1995 Sep;72(3):531-4. doi: 10.1038/bjc.1995.369. Br J Cancer. 1995. PMID: 7669557 Free PMC article.
-
Delivering cancer care: a model from the West Midlands.Br J Cancer. 1996 Sep;74(5):667-9. doi: 10.1038/bjc.1996.419. Br J Cancer. 1996. PMID: 8795566 Free PMC article.
-
Impact of Provider Volume on Outcomes of Patients With Hodgkin Lymphoma.World J Oncol. 2018 Apr;9(2):46-49. doi: 10.14740/wjon1093w. Epub 2018 May 1. World J Oncol. 2018. PMID: 29760832 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical